The relationship between plasma C-reactive protein levels and presence and severity of coronary stenosis in patients with stable angina

Angiology

Volumn 58, Issue 6, 2008, Pages 657-662

  Ulucay, Abdullah ^a   Demirbag, Recep ^a,b   Yilmaz, Remzi ^a   Unlu, Durmus ^a   Gur, Mustafa ^a   Selek, Sahabettin ^a   Celik, Hakim ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYSIS OF COVARIANCE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 37849026024     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707309118     Document Type: Article

References (26)

1. Ross R.: Atherosclerosis, an inflammatory disease. N Engl J Med 340: 115-126, 2004.
2. Libby P., Ridker PM, Maseri A.: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
3. Ridker PM: High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813-1818, 2001.
4. Yudkin JS, Stehouwer CD, Emeis JJ,, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978, 1999.
5. Liuzzo G., Biasucci LM, Gallamore JR,, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-424, 1994.
6. Avanzas P., Arroyo-Espliguero R., Cosin-Sales J.,, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90: 847-852, 2004.
7. Anderson JL, Carlquist JF, Muhlestein JB,, et al. Evaluation of C-reactive protein, an inflammatory marker, and infection serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32: 35-41, 1998.
8. Turkoglu EI, Gurgun C., Zoghi M.,, et al. The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise test. Anadolu Kardiyol Derg 4: 199-202, 2004.
9. Taniguchi H., Momiyama Y., Ohmori R.,, et al. Association of plasma levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178: 173-177, 2005.
10. Haidari M., Javadi E., Sadeghi B.,, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 33: 309-315, 2001.
11. Veselka J., Prochazkova S., Duchonova R.,, et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13: 151-154, 2002.
12. Azar RR, Aoun G., Fram DB,, et al. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise test. Am J Cardiol 86: 205-207, 2000.
13. Gensini GG A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51: 606, 1983.
14. Ridker PM, Buring JE, Shih J.,, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733, 1998.
15. Heinrich J., Schulte H., Schonfeld R.,, et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73: 374-378, 1995.
16. Haverkate F., Thompson SG, Pyke SD,, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349: 462-466, 1997.
17. Toss H., Lindahl B., Siegbahn A.,, et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96: 4204-4210, 1997.
18. Rebuzzi AG, Quaranta G., Liuzzo G.,, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 82: 715-719, 1998.
19. Auer J., Berent R., Lassnig E.,, et al. C-reactive protein and coronary artery disease. Jpn Heart J 43: 607-619, 2002.
20. Hoffmeister A., Rothenbacher D., Bazner U.,, et al. Role of markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87: 262-266, 2001.
21. Garcia-Moll X., Zouridakis E., Cole D.,, et al. C-reactive protein in patients with chronic stable angina: Differences in baseline serum concentration between women and men. Eur Heart J 21: 1598-1606, 2000.
22. Avanzas P., Arroyo-Espliguero R., Cosin-Sales J.,, et al. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175: 151-157, 2004.
23. Ridker PM, Hennekens CH, Rifai N.,, et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100: 713-716, 1999.
24. Ridker PM, Cushman M., Stampfer MJ,, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997.
25. Horne BD, Muhlestein JB, Carlquist JF,, et al. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 36: 1774-1780, 2000.
26. Ridker PM, Rifai N., Clearfield M.,, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959-1965, 2001.